Total, Free (MN+NMN)

Optimal result: 0 – 205 pg/mL

An elevated Total, Free (MN+NMN) level, which measures the combined levels of metanephrine (MN) and normetanephrine (NMN) in a biological sample, typically suggests an increased production or impaired metabolism of catecholamines. This measurement is often associated with the functioning of the sympathetic nervous system and can be indicative of specific medical conditions, most notably pheochromocytoma and paraganglioma. Here are some key points about what an elevated Total, Free (MN+NMN) signifies:

→ Pheochromocytoma: Pheochromocytoma is a rare tumor that develops in the adrenal glands or other sympathetic nerve tissue. These tumors can produce excessive amounts of catecholamines, including epinephrine (adrenaline), norepinephrine, metanephrine, and normetanephrine. Elevated Total, Free (MN+NMN) levels in the blood or urine are often a strong indicator of pheochromocytoma. This condition can lead to severe hypertension (high blood pressure), heart palpitations, sweating, and other symptoms related to excessive catecholamine release.

→ Paraganglioma: Paragangliomas are tumors that can develop in various locations in the body, including nerve cells called paraganglia. Like pheochromocytomas, paragangliomas can produce elevated levels of catecholamines, leading to increased Total, Free (MN+NMN) levels in the blood or urine.

→ Other Neuroendocrine Tumors: In addition to pheochromocytoma and paraganglioma, elevated Total, Free (MN+NMN) levels can also be associated with other neuroendocrine tumors, albeit less commonly. These tumors may arise from various locations and can affect the levels of catecholamines and their metabolites.

→ Medications and Lifestyle Factors: While less common, certain medications and lifestyle factors, such as the use of specific medications or dietary choices, can influence catecholamine metabolism and potentially lead to temporarily elevated Total, Free (MN+NMN) levels. It's important for healthcare providers to consider these factors when interpreting results.

→ Lab Error or Sample Handling: As with any laboratory test, errors in sample collection, handling, or analysis can lead to inaccurate results. It's important for healthcare providers to ensure that samples are collected and processed correctly to minimize the risk of false positives.

An elevated Total, Free (MN+NMN) level is a valuable diagnostic clue that warrants further evaluation. Healthcare providers typically follow up with additional tests, such as imaging studies (e.g., CT scans, MRI) and more specific biochemical tests, to confirm or rule out the presence of an underlying medical condition. Managing and treating the underlying condition is essential to address the elevated catecholamine levels and associated symptoms.

The marker "Total, Free (MN+NMN)" typically refers to the measurement of both metanephrine (MN) and normetanephrine (NMN) levels in a biological sample, such as blood or urine. These two compounds, metanephrine and normetanephrine, are metabolites of catecholamines, specifically epinephrine and norepinephrine. Measuring their levels can provide important diagnostic information related to the functioning of the sympathetic nervous system and the presence of certain medical conditions.

The marker "Total, Free (MN+NMN)" typically refers to the measurement of both metanephrine (MN) and normetanephrine (NMN) levels in a biological sample, such as blood or urine. These two compounds, metanephrine and normetanephrine, are metabolites of catecholamines, specifically epinephrine and norepinephrine. Measuring their levels can provide important diagnostic information related to the functioning of the sympathetic nervous system and the presence of certain medical conditions.

Here's a breakdown of these components:

→ Metanephrine (MN): Metanephrine is a metabolite of epinephrine and, to a lesser extent, norepinephrine. It is produced as these catecholamines are broken down and metabolized in the body. Elevated levels of metanephrine can indicate increased production or impaired metabolism of epinephrine. High levels of metanephrine are often associated with conditions like pheochromocytoma and paraganglioma.

→ Normetanephrine (NMN): Normetanephrine, as previously discussed, is a metabolite of norepinephrine. Elevated levels of normetanephrine can suggest increased production or impaired metabolism of norepinephrine. It is also commonly associated with conditions such as pheochromocytoma and paraganglioma.

When both metanephrine (MN) and normetanephrine (NMN) levels are measured together as "Total, Free (MN+NMN)," it provides a more comprehensive assessment of catecholamine metabolism and the potential presence of certain medical conditions. The "total" aspect of this measurement indicates the combined levels of both metabolites.

The measurement of Total, Free (MN+NMN) is often used in the diagnosis and monitoring of conditions like pheochromocytoma, which is a rare tumor that can lead to excessive catecholamine production. Elevated levels of both metanephrine and normetanephrine in the blood or urine, when measured together, can be a strong indicator of this condition.

Interpreting the results of Total, Free (MN+NMN) requires consideration of reference ranges specific to the laboratory conducting the test, as these ranges can vary. Additionally, healthcare providers take into account the patient's clinical history and other diagnostic tests to arrive at a definitive diagnosis and determine the appropriate course of treatment if a medical condition is suspected.

Total, Free (MN+NMN)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Total, Free (MN+NMN) — 10,000+ markers explained
One Total, Free (MN+NMN) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro